Active	Status	Sponsor type	Region	Phase	Filter
13 Active 2 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Huang, Edmund
SAFE KIDNEY II, NCT05769582: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients	Recruiting	2/3	180	US	Anti-BK polyomavirus (AntiBKV)	Memo Therapeutics AG	BK Viremia; BKV DNAemia	11/24	11/24
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
Pham, Phuong-Thu
APPELHUS, NCT04889430 / 2020-005186-13: Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy	Recruiting	3	50	Europe, Japan, US, RoW	Iptacopan, LNP023	Novartis Pharmaceuticals, Novartis Pharma AG	Atypical Hemolytic Uremic Syndrome	09/28	03/29
Bunnapradist, Suphamai
GOOD-IDES-02, NCT05679401: A Study With Imlifidase in Anti-GBM Disease	Active, not recruiting	3	50	Europe, US, RoW	Imlifidase, IdeS, HMED-IdeS, Plasma exchange (PLEX), PE, Cyclophosphamide (CYC), Glucocorticoids	Hansa Biopharma AB	Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome, Good Pasture Syndrome	06/25	11/26
SAFE KIDNEY II, NCT05769582: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients	Recruiting	2/3	180	US	Anti-BK polyomavirus (AntiBKV)	Memo Therapeutics AG	BK Viremia; BKV DNAemia	11/24	11/24
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
ProActive, NCT04091984: The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry	Active, not recruiting	N/A	5000	US	Prospera	Natera, Inc., University of Maryland	Kidney Transplant Rejection	10/26	10/27
Gadzhyan, Janette
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
Datta, Nakul
SAFE KIDNEY II, NCT05769582: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients	Recruiting	2/3	180	US	Anti-BK polyomavirus (AntiBKV)	Memo Therapeutics AG	BK Viremia; BKV DNAemia	11/24	11/24
Abdalla, Basmah
No trials found
Sampaio, Marcelo
No trials found